Class 4 Medicines Defect Information: Zoledronic acid 5mg solution for infusion (MDR 51-03/19)

Ranbaxy (UK) Ltd a Sun Pharmaceutical Company, has informed us that some packs from a batch of Zoledronic acid 5mg solution for infusion contain a Patient Information Leaflet for Temozolomide 180mg Capsules.

Company name

Sun Pharmaceutical Industries Europe BV

Product description

Zoledronic acid 5mg solution for infusion (PL 31750/0054)

Batch Number Expiry Date Pack Size First Distributed
JKT1576A 30 April 2020 1 x 100ml 12 October 2018

Brief description of the problem

Ranbaxy (UK) Ltd a Sun Pharmaceutical Company, has informed us that some packs from the above batch contain a Patient Information Leaflet (PIL) for Temozolomide 180mg Capsules.

Advice for healthcare professionals

When dispensing the above batch, please check the Patient Information Leaflet (PIL). If the pack contains the wrong PIL, please remove it and provide a copy of the correct PIL. This can be downloaded via the following link: https://www.medicines.org.uk/emc/product/5242/pil

Further information

For any enquiries, please contact Ranbaxy / Sun Pharmaceuticals customer services team:

Email: cserv.uk@sunpharma.com

Tel: 020 8848 5050

Download the document

Drug alert: Zoledronic acid 5mg solution for infusion (MDR 51-03/19)

Recipients of this Drug Alert should bring it to the attention of relevant contacts by copy of this letter.

Published 4 April 2019